Marc Pineton de Chambrun

ORCID: 0000-0002-6321-858X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • Systemic Lupus Erythematosus Research
  • Mechanical Circulatory Support Devices
  • Cancer Immunotherapy and Biomarkers
  • Eosinophilic Disorders and Syndromes
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Cardiac Arrest and Resuscitation
  • Immunodeficiency and Autoimmune Disorders
  • Inflammatory Myopathies and Dermatomyositis
  • Viral Infections and Immunology Research
  • Monoclonal and Polyclonal Antibodies Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cardiac Structural Anomalies and Repair
  • Muscle and Compartmental Disorders
  • Respiratory Support and Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • COVID-19 Clinical Research Studies
  • Vasculitis and related conditions
  • Peripheral Neuropathies and Disorders
  • SARS-CoV-2 and COVID-19 Research
  • Lymphoma Diagnosis and Treatment
  • Renal Diseases and Glomerulopathies
  • Hepatitis C virus research
  • Long-Term Effects of COVID-19
  • Ocular Diseases and Behçet’s Syndrome

Sorbonne Université
2016-2025

Assistance Publique – Hôpitaux de Paris
2015-2025

Inserm
2011-2025

Pitié-Salpêtrière Hospital
2016-2025

Fondation pour l’innovation en Cadiométabolisme et Nutrition
2017-2025

Centre d'Immunologie et des Maladies Infectieuses
2019-2025

Imation (United States)
2022-2025

Université de Lorraine
2025

French Clinical Research Infrastructure Network
2025

Réanimation et soins intensifs du patient en Insuffisance respiratoire aigüe
2022-2024

Guillaume Lebreton Matthieu Schmidt Maharajah Ponnaiah Thierry Folliguet Marylou Para and 95 more Julien Guihaire Emmanuel Lansac Édouard Sage Bernard Cholley Bruno Mégarbane Pierrick Cronier Jonathan Zarka Daniel Da Silva Sébastien Besset Tristan Morichau-Beauchant Igor Lacombat Nicolas Mongardon Christian Richard Jacques Duranteau Charles Cerf Gabriel Saiydoun Romain Sonneville Jean‐Daniel Chiche Patrick Nataf Dan Longrois Alain Combes Pascal Leprince Charles Juvin Thibault Schoell Cosimo D’Alessandro Sofica Marin Nathalie Nardone Pierre Demondion Horacio MEYER Karl Bounader Alexander MOIROUX Ali Akamkam Guillaume Fadel Erwan RANDRIANALISOA Sébastien CUSQUEL Patrice LE GLOAHEC Elisabeth HIRSCHAUER Fabrice MUSQUET Pierre-Marie Jego Hélène Guedes Théophile Roy Lina Mercereau Emmanuel Corvol Anne Laboure Flore Vilanove Marco Peperoni Dariène Machado Aly Sely Marion Fortanier Séverine Gantois Émilie Tran Elisabeth Bosq Aurélie Fontanier Alice Morin Jocelyne Cousin Stéphanie Bovagnet Charles Edouard Luyt Guillaume Hékimian Nicolas Bréchot Marc Pineton de Chambrun Cyrielle Desnos Juliette Chomeloux Jérémy Arzoine Emmanuelle Guerin Antoine Monsel Guillaume Voiriot David Levy Ėlodie Baron Alexandra Beurton Juliette Chommeloux Paris Meng Safaa Nemlaghi Pierre Bay Alexandre Demoule Bertrand Guidet Jean Michel Constantin Muriel Fartoukh Martin Dres Patrick Nataf Guillaume Franchineau Lucie Le Fèvre Richard Raffoul Soleiman Alkhoder Walid Ghodbane Angelo Pisani Wael Braham A. Gara Pierre Mordant Yves-Hervé CASTIER Étienne de Montmollin Lila Bouadma Jean‐François Timsit Olivier Langeron Quentin de Roux Claire Alessandri

In the Île-de-France region (henceforth termed Greater Paris), extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) was considered early in COVID-19 pandemic. We report ECMO network organisation and outcomes during first wave of pandemic.In this multicentre cohort study, we present an analysis all adult patients with laboratory-confirmed SARS-CoV-2 infection ARDS requiring who were admitted to 17 Paris intensive care units between March 8 June 3,...

10.1016/s2213-2600(21)00096-5 article EN publisher-specific-oa The Lancet Respiratory Medicine 2021-04-20

Immune-checkpoint-inhibitor (ICI)-associated myotoxicity involves the heart (myocarditis) and skeletal muscles (myositis), which frequently occur concurrently are highly fatal. We report results of a strategy that included identification individuals with severe ICI myocarditis by also screening for managing concomitant respiratory muscle involvement mechanical ventilation, as well treatment CTLA4 fusion protein abatacept JAK inhibitor ruxolitinib. Forty cases definite were pathologic...

10.1158/2159-8290.cd-22-1180 article EN Cancer Discovery 2023-02-23
Xavier Puéchal Christian Pagnoux Gabriel Baron T. Quéméneur A. Néel and 95 more C. Agard François Lifermann É. Liozon M. Ruivard Pascal Godmer Nicolas Limal A. Mékinian T. Papo A.-M. Ruppert A. Bourgarit Boris Bienvenu L. Geffray Luc Saraux Élisabeth Diot Bruno Crestani X. Delbrel L. Sailler Pascal Cohen Véronique Le Guern Benjamin Terrier Matthieu Groh Claire Le Jeunne Luc Mouthon Philippe Ravaud Loı̈c Guillevin Marc Pineton de Chambrun Charles‐Édouard Luyt François Beloncle Marie Gousseff Wladimir Mauhin Laurent Argaud Stanislas Ledochowski Anne-Sophie Moreau Romain Sonneville Bruno Verdière Sybille Merceron Nathalie Zappella Mickaël Landais Damien Contou Alexandre Demoule S. Paulus Bertrand Souweine Bernard Lecomte Antoine Vieillard‐Baron Nicolas Terzi Elie Azoulay Raymond Friolet M. Puidupin Jérôme Devaquet Jean-Marc Mazou Yannick Fédun Jean‐Paul Mira M. Pha Alain Combes Zahir Amoura Jean‐Christophe Lega M. Lambert Sophie Rivière Antoine Dossier François Lhote Thomas Gille Laurent Alric David Saadoun J. Graveleau Martin Soubrier Marie-Josée Lecomte Christine Christides A. Bosseray H. Lévesque François Viallard N. Tieulié Pierre‐Yves Lovey S. Le Moal B. Bibes Giuseppe Malizia P. Abgueguen François Liferman J. Ninet Pierre-Yves Hatron A. Hot Romain Hernu Sylvie de la Salle Thomas Similowski Julien Haroche J. Boileau Thomas Hanslik Caroline Bulte Aline Talasczka É. Hachulla Olivier Decaux Florent Ibouanga Bertrand Arnulf M. Benedit Assaad Maalouf Bruno Moulin

In most patients with nonsevere systemic necrotizing vasculitides (SNVs), remission is achieved glucocorticoids alone, but one-third experience a relapse within 2 years. This study was undertaken to determine whether the addition of azathioprine (AZA) could achieve higher sustained rate newly diagnosed eosinophilic granulomatosis polyangiitis (Churg-Strauss) (EGPA), microscopic (MPA), or polyarteritis nodosa (PAN).All included in this double-blind trial received glucocorticoids, gradually...

10.1002/art.40205 article EN Arthritis & Rheumatology 2017-07-05

The data on incidence, clinical presentation, and outcomes of ventilator-associated pneumonia (VAP) in patients with severe coronavirus disease 2019 (COVID-19) requiring mechanical ventilation (MV) are limited. We performed this retrospective cohort study to assess frequency, characteristics, responsible pathogens, VAP COVID-19 MV between March 12th April 24th, 2020 (all had RT-PCR-confirmed SARS-CoV-2 infection). Patients COVID-19-associated acute respiratory distress syndrome (ARDS) ECMO...

10.1186/s13613-020-00775-4 article EN cc-by Annals of Intensive Care 2020-11-23

To compare the efficacy to prevent flares of maintenance versus withdrawal 5 mg/day prednisone in systemic lupus erythematosus (SLE) patients with clinically quiescent disease. A monocentric, 12-month, superiority, open-label, randomised (1:1) controlled trial was conducted 61 continuing and 63 stopping it. Eligibility criteria were SLE who, during year preceding inclusion, had a inactive disease stable treatment including prednisone. The primary endpoint proportion patient experiencing...

10.1136/annrheumdis-2019-216303 article EN Annals of the Rheumatic Diseases 2019-12-18

Coronavirus disease 2019 (COVID-19) is associated with a systemic coagulopathy 1 favoring thromboembolic complications, which occur in 15% to 30% of critically ill patients COVID-19. 2,3This remains poorly documented and data on thrombin generation fibrinolysis are lacking.We characterized the coagulation profiles CO-VID-19 acute respiratory distress syndrome (ARDS).From October April 2020, 28 consecutive severe ARDS were referred our tertiary intensive care unit included this prospective...

10.1161/circulationaha.120.048925 article EN mit Circulation 2020-06-17

Anti-synthetase (AS) and dermato-pulmonary associated with anti-MDA-5 antibodies (aMDA-5) syndromes are near one of the other autoimmune inflammatory myopathies potentially responsible for severe acute interstitial lung disease. We undertook a 13-year retrospective multicenter study in 35 French ICUs order to describe clinical presentation outcome patients admitted ICU respiratory failure (ARF) revealing AS or aMDA-5 syndromes.From 2005 2017, 47 (23 males; median age 60 [1st-3rd quartiles...

10.1186/s13613-018-0433-3 article EN cc-by Annals of Intensive Care 2018-09-10

Extracorporeal membrane oxygenation (ECMO) was frequently used to treat patients with severe coronavirus disease-2019 (COVID-19)-associated acute respiratory distress (ARDS) during the initial outbreak. Care of COVID-19 evolved markedly second part 2020. Our objective compare characteristics and outcomes who received ECMO for ARDS before or after July 1, We included consecutive adults diagnosed in Paris-Sorbonne University Hospital Network ICUs, until January 28, 2021. Characteristics...

10.1186/s13054-021-03780-6 article EN cc-by Critical Care 2021-10-09

Recent multicenter studies identified COVID-19 as a risk factor for invasive pulmonary aspergillosis (IPA). However, no large study has compared the incidence of IPA between and influenza patients.To determine putative in critically ill SARS-CoV-2 patients, with patients.This was planned ancillary analysis coVAPid retrospective European cohort. Consecutive adult patients requiring mechanical ventilation > 48 h pneumonia or were included. The 28-day cumulative IPA, based on Blot definition,...

10.1186/s13054-021-03874-1 article EN cc-by Critical Care 2022-01-04

Prone positioning (PP) reduces mortality of patients with acute respiratory distress syndrome (ARDS). The potential benefit prone maneuvers during venovenous extracorporeal membrane oxygenation (ECMO) is unknown. aim this study was to evaluate the association between use support and ICU in a pooled population from previous European cohort studies.We performed individual patient data analysis studies which compared treated ECMO (Prone group) "conventional" management (Supine severe ARDS.889...

10.1186/s13054-021-03879-w article EN cc-by Critical Care 2022-01-06

Abstract Background Fulminant myocarditis (FM) is a severe condition primarily triggered by viruses. Anti-RNA polymerase III autoantibodies (RNApol3) which are typically found in patients with systemic sclerosis, have been reported influenza-related FM. Our objective to provide additional insight into RNApol3-associated Methods We retrospectively included all admitted our institution between January 2013 and June 2023 acute positive serum RNApol3. compared their characteristics, etiologies,...

10.1186/s13613-025-01443-1 article EN cc-by Annals of Intensive Care 2025-03-24

Abstract Background Preliminary evidence from small, single-center studies suggests levosimendan may improve the likelihood of successful venoarterial extracorporeal membrane oxygenation (VA-ECMO) weaning in patients with cardiogenic shock. However, literature is limited and presents conflicting results. We aimed to assess benefits on VA-ECMO for time ECMO weaning, using a pragmatic rigorous definition potential cardiac function recovery. Methods A retrospective bicentric study over 6 years...

10.1186/s13613-025-01457-9 article EN cc-by Annals of Intensive Care 2025-04-03

Behcet's disease (BD) is a well-known cause of Budd-Chiari syndrome (BCS). Data are lacking on the presentation and outcome BCS related to BD. We investigated relationship between BD in 14 patients with both diseases compared results 92 without Male gender (p = 0.003), North African origin (P 0.007) inferior vena cava obstruction < 0.0001) were more frequent than those alone plasma C-reactive protein level was higher 0.003). Two combined underwent recanalization hepatic veins, none received...

10.1186/s13023-014-0153-1 article EN cc-by Orphanet Journal of Rare Diseases 2014-09-13
Marc Pineton de Chambrun Marie Gousseff Wladimir Mauhin Jean‐Christophe Lega M. Lambert and 95 more Sophie Rivière Antoine Dossier M. Ruivard François Lhote Thomas Gille Laurent Alric C. Agard David Saadoun J. Graveleau Martin Soubrier Marie-Josée Lucchini-Lecomte Christine Christides A. Bosseray H. Lévesque Jean‐François Viallard N. Tieulié Pierre‐Yves Lovey S. Le Moal B. Bibes Giuseppe Malizia P. Abgueguen François Lifermann J. Ninet Pierre‐Yves Hatron Zahir Amoura Marc Pineton de Chambrun Marie Gousseff Wladimir Mauhin Arnaud Hot Laurent Argaud Romain Hernu T. Papo Jean‐Christophe Lega Stanislas Ledochowski M. Lambert Anne‐Sophie Moreau Sophie Rivière Antoine Dossier T. Papo Romain Sonneville M. Ruivard François Lhote Bruno Verdière Thomas Gille Sybille Merceron Nathalie Zappella Laurent Alric Christian Agard Mickaël Landais Nicolas Limal Damien Contou David Saadoun Thomas Similowski Alexandre Demoule Thomas Similowski Julie Graveleau Martin Soubrier Bertrand Souweine Julien Haroche J. Boileau Marie-Josée Lucchini-Lecomte Bernard Lecomte Thomas Hanslik Antoine Vieillard-Baron Christine Christides A. Bosseray Nicolas Terzi H. Lévesque Caroline Bulte Aline Talasczka É. Hachulla Olivier Decaux Florent Ibouanga Bertrand Arnulf Matthieu Groh Elie Azoulay Marcel Benedit Jean‐François Viallard N. Tieulié Assaad Maalouf Bruno Moulin Fleur Cohen-Aubart Pierre-Yves Lovey Raymond Friolet S. Le Moal B. Bibes M. Pha Georges‐Étienne Rivard Eric Rondeau Giuseppe Malizia P. Debourdeau M. Puidupin P. Abgueguen François Beloncle Jérôme Devaquet

10.1016/j.amjmed.2017.05.023 article EN The American Journal of Medicine 2017-06-10

Maintenance of remission has become central in the management systemic lupus erythematosus (SLE). The importance interferon-alpha (IFN-α) pathogenesis SLE notwithstanding, its expression been poorly studied as yet. To study and prognostic value prediction a disease relapse, serum IFN-α levels were determined using an ultrasensitive single-molecule array digital immunoassay which enables measurement cytokines at physiological concentrations.A total 254 patients remission, according to...

10.1136/annrheumdis-2019-215571 article EN Annals of the Rheumatic Diseases 2019-09-30

Objective: Systemic capillary-leak syndrome is a very rare cause of recurrent hypovolemic shock. Few data are available on its clinical manifestations, laboratory findings, and outcomes those patients requiring ICU admission. This study was undertaken to describe the pictures management severe systemic episodes. Design, Setting, Patients: multicenter retrospective analysis concerned entered in European Clarkson’s disease (EurêClark) Registry admitted ICUs between May 1992 February 2016....

10.1097/ccm.0000000000002496 article EN Critical Care Medicine 2017-06-17

No simple or standardized assay is available to quantify interferon-α (IFNα) in routine clinical practice. Single-molecule array (Simoa) digital enzyme-linked immunosorbent (ELISA) technology enables direct IFNα quantification at attomolar (femtogram per milliliter [fg/ml]) concentrations. This study was undertaken assess ELISA diagnostic performances monitor systemic lupus erythematosus (SLE) activity. concentrations serum samples from 150 consecutive SLE patients a cross-sectional were...

10.1002/art.40792 article EN Arthritis & Rheumatology 2018-12-03
Coming Soon ...